Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › IMCR
FARALLON CAPITAL MANAGEMENT, L.L.C. position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 928,000 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$28.1M, representing 0.12% of its reported portfolio and ranking #48 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How FARALLON CAPITAL MANAGEMENT, L.L.C.'s IMCR position evolved
FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in IMCR in Q3 2026 at 928,000 shares (US$28.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 928.00K | $28.11M | New |
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 26 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $147.51M · Q3 2026
- Bellevue Group AG 2.79M sh · $88.53M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.65M sh · $84.12M · Q2 2026
- Vestal Point Capital, LP 1.80M sh · $57.15M · Q2 2026
- Caligan Partners LP 1.38M sh · $43.86M · Q2 2026
- Kynam Capital Management, LP 1.38M sh · $41.65M · Q3 2026
- BVF INC/IL 1.29M sh · $41.10M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.14M sh · $34.41M · Q3 2026
- Trails Edge Capital Partners, LP 1.06M sh · $32.21M · Q3 2026
- Frazier Life Sciences Management, L.P. 484.78K sh · $15.39M · Q2 2026
- Logos Global Management LP 500.00K sh · $15.14M · Q3 2026
More on FARALLON CAPITAL MANAGEMENT, L.L.C.
FAQ
How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held IMCR?
FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed IMCR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in IMCR?
As of Q3 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 928.00K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $28.11M, representing 0.12% of its reported portfolio and ranking #48.
Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling IMCR?
In the latest 13F filing (Q3 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. newly opened its position in IMCR.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.